Esflurbiprofen transdermal (Teikoku Seiyaku)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEsflurbiprofen transdermal (Teikoku Seiyaku)
Drug Alias NameEsflurbiprofen Hydrogel PatchTK-254RXTK-254R
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsContusionsSprains and StrainsSoft Tissue Injuries +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTeikoku Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTeikoku Seiyaku Co Ltd
Inactive CompaniesN/A
Active IndicationsContusionsSprains and StrainsSoft Tissue Injuries +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A